A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomas.

Source:http://linkedlifedata.com/resource/pubmed/id/15739208

Cancer 2005 Apr 1 103 7 1431-8

Download in:

View as

Triples

General Info

PMID
15739208